Intratus is a clinical-stage life sciences company dedicated to the development of its patented non-invasive drug delivery platform technologies. Its portfolio is focused on the treatment of a multitude of ophthalmic diseases in all segments of the eye. Additionally, the company develops a platform technology that extends to systemic diseases such as cardiovascular disease, diabetes, and allergy and immunology.